EA200601180A2 - METHOD OF MANUFACTURING TABLETED DRUG FORM OF TRIMETHAZIDINE DIHYDROCHLORIDE AND ITS COMPOSITION - Google Patents
METHOD OF MANUFACTURING TABLETED DRUG FORM OF TRIMETHAZIDINE DIHYDROCHLORIDE AND ITS COMPOSITIONInfo
- Publication number
- EA200601180A2 EA200601180A2 EA200601180A EA200601180A EA200601180A2 EA 200601180 A2 EA200601180 A2 EA 200601180A2 EA 200601180 A EA200601180 A EA 200601180A EA 200601180 A EA200601180 A EA 200601180A EA 200601180 A2 EA200601180 A2 EA 200601180A2
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- trimetazidine dihydrochloride
- dihydrochloride
- plasdon
- talc
- antioxidant
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Изобретение относится к фармацевтической промышленности, а именно к таблетированной лекарственной форме триметазидина дигидрохлорида, обладающей антиагрегантной, антиангиальной, антиоксидантной, вазодилатирующей, коронародилатирующей, противогипоксической, церебровазодилатирующей активностью и активностью для лечения головокружения, применяемой в качестве цитопротекторного и антигипоксантного средства, а также в качестве антиоксиданта, и к усовершенствованному способу её получения. Таблетированная лекарственная форма содержит в своем ядре в качестве активного вещества триметазидина дигидрохлорид и в качестве вспомогательных веществ - гипролозу Клуцел LF, крахмал кукурузный, лактозу, соль стеариновой кислоты и тальк, а в своем покрытии (оболочке) - гидроксипропилметилцеллюлозу, Пласдон S-630, полиэтиленгликоль, тальк, титана диоксид и краситель - окись железа (III) красную или понсо при соотношении, указанном в формуле изобретения. Настоящий способ обеспечивает полную механизацию процесса изготовления, обеспечивающую высокую производительность, чистоту и гигиеничность таблеток; точность дозирования и быстроту высвобождения триметазидина дигидрохлорида; высокую биодоступность активного вещества; длительную сохранность лекарственных веществ в спрессованном состоянии; фармацевтическую совместимость и оптимальное сочетание триметазидина дигидрохлорида и вспомогательных веществ; локализацию действия лекарственного препарата. Таблетки обладают хорошей распадаемостью, высокой прочностью и биодоступностью.The invention relates to the pharmaceutical industry, namely to the tableted dosage form trimetazidine dihydrochloride having antiplatelet, antiangialnoy, antioxidant, vasodilating, vasodilatig, antihypoxic, tserebrovazodilatiruyuschey activity and activity for the treatment of vertigo, used as cytoprotective and antihypoxic agents, as well as an antioxidant, and to an improved way of getting it. The tablet dosage form contains trimetazidine dihydrochloride in its core as an active substance, and six-sided hyperlose Klucel LF, corn starch, lactose, stearic acid and talc as excipients, and hydroxypropylmethyl cellulose, Plasdon S-6 in its coating (shell), hydroxypropylmethylcellulose, Plasdon S-6. , talc, titanium dioxide and the dye is iron (III) oxide red or ponco with the ratio specified in the claims. This method provides a complete mechanization of the manufacturing process, providing high performance, cleanliness and hygiene tablets; dosing accuracy and quick release of trimetazidine dihydrochloride; high bioavailability of the active substance; long-term preservation of medicinal substances in a compressed state; pharmaceutical compatibility and optimal combination of trimetazidine dihydrochloride and auxiliary substances; localization of drug action. Tablets have good disintegration, high strength and bioavailability.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200601180A EA009776B1 (en) | 2006-07-18 | 2006-07-18 | Method for preparing tablets of dihydrochloride trimethazine and composition thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200601180A EA009776B1 (en) | 2006-07-18 | 2006-07-18 | Method for preparing tablets of dihydrochloride trimethazine and composition thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
EA200601180A2 true EA200601180A2 (en) | 2006-12-29 |
EA200601180A3 EA200601180A3 (en) | 2007-04-27 |
EA009776B1 EA009776B1 (en) | 2008-04-28 |
Family
ID=40848887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200601180A EA009776B1 (en) | 2006-07-18 | 2006-07-18 | Method for preparing tablets of dihydrochloride trimethazine and composition thereof |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA009776B1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3262852A (en) * | 1966-07-26 | Vasodilator and anti-anginose com- pounds containing methoxy benzyl piperazines and method of using the same | ||
FR2490963B1 (en) * | 1980-09-30 | 1986-04-18 | Science Union & Cie | NOVEL THERAPEUTIC COMPOSITION WITH ANTI-ISCHEMIC ACTION CONTAINING TRIMETHOXY 2, 3, 4-BENZYL 1-PIPERAZINE |
FR2802424B1 (en) * | 1999-12-17 | 2002-02-15 | Adir | MATRIX TABLET FOR THE EXTENDED RELEASE OF TRIMETAZIDINE AFTER ORAL ADMINISTRATION |
-
2006
- 2006-07-18 EA EA200601180A patent/EA009776B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA009776B1 (en) | 2008-04-28 |
EA200601180A3 (en) | 2007-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7683054B2 (en) | Galenic formulations of organic compounds | |
BR112020024125A2 (en) | pharmaceutical combination, composition and preparation of compound comprising glucokinase activator and dpp-iv inhibitor, and method of preparation and use thereof | |
EA200702627A1 (en) | DOSED FORMS FOR ORAL APPLICATION, CONTAINING PROGESTERONS, AND METHODS OF THEIR MANUFACTURING AND USE | |
US20220233514A1 (en) | Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonate | |
RU2760304C2 (en) | Pharmaceutical compositions with deferred release containing valproic acid and their use | |
US20120141586A1 (en) | Thrombin receptor antagonist and clopidogrel fixed dose tablet | |
RU2704613C2 (en) | Pharmaceutical preparations with fixed combination of analgesic and antispasmodic agents doses | |
WO2012161240A1 (en) | Dry-coated tablet containing tegafur, gimeracil and oteracil potassium | |
EA200601180A2 (en) | METHOD OF MANUFACTURING TABLETED DRUG FORM OF TRIMETHAZIDINE DIHYDROCHLORIDE AND ITS COMPOSITION | |
AU2012326976B2 (en) | Sustained-release preparation | |
HUP0300378A2 (en) | Oxazolidinone tablet formulation and their preparation | |
US8968779B2 (en) | Controlled release coat-core tablet | |
JP5694177B2 (en) | Film-coated tablets with suppressed discoloration and odor | |
CN104435384B (en) | A kind of anti-inflammation slow releasing tablet | |
RU2674978C2 (en) | Pharmaceutical composition of n-[5-[2-(3,5-dimethoxyphenyl) ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl] benzamide | |
RU2580656C1 (en) | Immediate-release solid dosage form of hydroxychloroquine and method for producing it | |
EA200701499A1 (en) | DOSAGE FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | |
US20190054026A1 (en) | Solid preparation | |
HUP0300770A2 (en) | Tartrate salt of thiazolidinedione derivative | |
RU2453315C2 (en) | Pharmaceutical composition for allergic diseases | |
RU2412706C1 (en) | Modified release dosage form of trimetazidine dihydrochloride | |
EP3335703A1 (en) | Pharmaceutical composition comprising omarigliptin | |
EP2323633B1 (en) | Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor | |
WO2023003497A1 (en) | Compounds with lysosomotropic and antiviral activity | |
RU2314099C1 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ BY KZ |
|
QB4A | Registration of a licence in a contracting state |